cardiovascular benefits of glp 1 agonists GLP-1 receptor for health GLP-1 Receptor Agonists in Heart
Description
CanonCLeibnerLFantonMChangZSurajVLeeJet al
2025;26(7):e13916
Obesity, hypertriglyceridemia, and metabolic syndromeconditions commonly present in patients prescribed GLP-1 agonistsare themselves established risk factors for pancreatic inflammation
doi: 10.1001/jama.2024.6586
The progressive form, MASH, exhibits hepatocyte damage, inflammatory cell infiltration, and variable degrees of tissue fibrosis, with advanced fibrosis representing the predominant prognostic determinant for hepatic morbidity and mortality, as well as an additional risk factor for extrahepatic complications
doi: 10.1523/JNEUROSCI.2107-12.2012 219 IwaiTSawabeTTanimitsuKSuzukiMSasaki-HamadaSOkaJ
